GetTopicDetailResponse(id=236a835483a, topicName=膽道腫瘤, introduction=膽道腫瘤, content=null, image=null, comments=2, allHits=1603, url=https://h5.medsci.cn/topic?id=83548, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=2871, tagList=[TagDto(tagId=2871, tagName=膽道腫瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2198980, encodeId=a343219898045, content=<a href='/topic/show?id=5a1f52411f6' target=_blank style='color:#2F92EE;'>#急性胰腺炎#</a> <a href='/topic/show?id=236a835483a' target=_blank style='color:#2F92EE;'>#膽道腫瘤#</a>, objectTitle=UEGJ：急性胰腺炎與膽道惡性腫瘤的關(guān)系, objectType=article, longId=822031, objectId=ac45822031d2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696890850643_4754896.jpeg, objectUrl=/article/show_article.do?id=ac45822031d2, replyNumber=0, likeNumber=129, createdTime=2024-04-17, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ac45822031d2, moduleTitle=UEGJ：急性胰腺炎與膽道惡性腫瘤的關(guān)系, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ac45822031d2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2168552, encodeId=cec021685523b, content=<a href='/topic/show?id=236a835483a' target=_blank style='color:#2F92EE;'>#膽道腫瘤#</a> 2023年11月8日，中山大學(xué)許麗霞、李曉星及香港中文大學(xué)于君共同通訊在Cell Reports Medicine 在線發(fā)表題為“Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application”的研究論文，該研究從82個(gè)腫瘤(74.4%)中生成了61個(gè)BTC患者來源的類器官(PDOs)，這些類器官顯示出與相應(yīng)的原發(fā)性BTC組織相似的組織學(xué)和遺傳特征。, objectTitle=膽道腫瘤, objectType=topic, longId=83548, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=74, createdTime=2023-11-14, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=浙江省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1193817, encodeId=425a119381e70, content=<a href='/topic/show?id=236a835483a' target=_blank style='color:#2F92EE;'>#膽道腫瘤#</a>, objectTitle=光動(dòng)力治療膽道腫瘤效果明顯, objectType=article, longId=30171, objectId=d92e301e1a2, topicUrl=null, isHasObj=0, objectCover=, objectUrl=/article/show_article.do?id=d92e301e1a2, replyNumber=0, likeNumber=119, createdTime=2022-02-15, rootId=0, userName=醫(yī)者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d92e301e1a2, moduleTitle=光動(dòng)力治療膽道腫瘤效果明顯, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d92e301e1a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
關(guān)注
已關(guān)注
2020-05-29
前往app查看評(píng)論內(nèi)容
全文
收起
#膽道腫瘤# 2023年11月8日，中山大學(xué)許麗霞、李曉星及香港中文大學(xué)于君共同通訊在Cell Reports Medicine 在線發(fā)表題為“Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application”的研究論文，該研究從82個(gè)腫瘤(74.4%)中生成了61個(gè)BTC患者來源的類器官(PDOs)，這些類器官顯示出與相應(yīng)的原發(fā)性BTC組織相似的組織學(xué)和遺傳特征。
